698 results match your criteria Lecithin-Cholesterol Acyltransferase Deficiency


Lecithin:Cholesterol Acyltransferase: Symposium on 50-years of biomedical research from its discovery to latest findings.

J Lipid Res 2020 Jun 1. Epub 2020 Jun 1.

Oslo University Hospital, Norway

Lecithin:cholesterol acyltransferase (LCAT) converts free cholesterol to cholesteryl esters in the process of reverse cholesterol transport. Familial LCAT deficiency (FLD) is a genetic disease that was first described by Kaare R. Norum and Egil Gjone in 1967. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1194/jlr.S120000720DOI Listing

Novel lecithin: cholesterol acyltransferase-based therapeutic approaches.

Curr Opin Lipidol 2020 Apr;31(2):71-79

Lipoprotein Metabolism Laboratory, Translational Vascular Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda.

Purpose Of Review: To review recent lecithin:cholesterol acyltransferas (LCAT)-based therapeutic approaches for atherosclerosis, acute coronary syndrome, and LCAT deficiency disorders.

Recent Findings: A wide variety of approaches to using LCAT as a novel therapeutic target have been proposed. Enzyme replacement therapy with recombinant human LCAT is the most clinically advanced therapy for atherosclerosis and familial LCAT deficiency (FLD), with Phase I and Phase 2A clinical trials recently completed. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOL.0000000000000673DOI Listing

LCAT protects against Lipoprotein-X formation in a murine model of drug-induced intrahepatic cholestasis.

Pharmacol Res Perspect 2020 02 29;8(1):e00554. Epub 2019 Dec 29.

Lipoprotein Metabolism Section Translational Vascular Medicine Branch National Heart Lung and Blood Institute National Institutes of Health Bethesda MD USA.

Familial lecithin:cholesterol acyltransferase (LCAT) deficiency (FLD) is a rare genetic disease characterized by low HDL-C levels, low plasma cholesterol esterification, and the formation of Lipoprotein-X (Lp-X), an abnormal cholesterol-rich lipoprotein particle. LCAT deficiency causes corneal opacities, normochromic normocytic anemia, and progressive renal disease due to Lp-X deposition in the glomeruli. Recombinant LCAT is being investigated as a potential therapy for this disorder. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/prp2.554DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6935572PMC
February 2020

LCAT, ApoD, and ApoA1 Expression and Review of Cholesterol Deposition in the Cornea.

Biomolecules 2019 11 26;9(12). Epub 2019 Nov 26.

Experimental Atherosclerosis Section, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Lecithin:cholesterol acyltransferase (LCAT) is an enzyme secreted by the liver and circulates with high-density lipoprotein (HDL) in the blood. The enzyme esterifies plasma cholesterol and increases the capacity of HDL to carry and potentially remove cholesterol from tissues. Cholesterol accumulates within the extracellular connective tissue matrix of the cornea stroma in individuals with genetic deficiency of LCAT. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/biom9120785DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6995527PMC
November 2019

[Inborn errors of high-density lipoprotein metabolism].

Internist (Berl) 2019 Dec;60(12):1311-1318

Institut für Klinische Chemie, Universitätsspital Zürich und Universität Zürich, Rämistrasse 100, 8091, Zürich, Schweiz.

Both low and very high levels of high-density lipoprotein cholesterol (HDL-C) increase the risk of atherosclerotic cardiovascular disease (ASCVD) and shorten life expectancy. Low and high levels of HDL‑C are often caused by underlying diseases, lifestyle or medication, which should primarily be excluded. Much less frequently, monogenic diseases due to mutations in the APOA1, ABCA1 and LCAT genes are the cause of very low or unmeasurable HDL‑C levels or in the CETP, LIPC and SCARB1 genes for very high HDL‑C values. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00108-019-00700-3DOI Listing
December 2019

Lipid Profile Rather Than the Mutation Explains Renal Disease in Familial LCAT Deficiency.

J Clin Med 2019 Nov 3;8(11). Epub 2019 Nov 3.

Lipid Unit, Hospital Universitario Miguel Servet, Instituto de Investigación Sanitaria Aragón (IIS Aragón), CIBER Cardiovascular (CIBERCV), 50009 Zaragoza, Spain.

Renal complications are the major cause of morbidity and mortality in patients with familial lecithin-cholesterol acyltransferase (LCAT) deficiency (FLD). We report three FLD patients, two of them siblings-only one of whom developed renal disease-and the third case being a young man with early renal disease. The aim of this study was to analyze the clinical characteristics and possible mechanisms associated with renal disease in these patients. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/jcm8111860DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912718PMC
November 2019

Hypercholesterolemia Due to Lipoprotein X: Case Report and Thematic Review.

Clin Med Insights Endocrinol Diabetes 2019 29;12:1179551419878687. Epub 2019 Sep 29.

Endocrinology Section, Fundación Santa Fe de Bogotá, Bogotá, Colombia.

The liver is a key organ in lipid and lipoprotein metabolism, hence hepatic diseases often manifest as lipid disturbances. Cholestatic liver diseases are frequently associated with an important increase in total cholesterol at the expense of lipoprotein X (LpX), an abnormal lipoprotein isolated and characterized in the 1960s to 1970s in patients with obstructive jaundice. Lipoprotein X is rich in phospholipids, albumin, and free cholesterol, has a density similar to low-density lipoprotein (LDL), and a size similar to very low-density lipoprotein (VLDL), which has hampered its detection through routine laboratory tests. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1179551419878687DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769215PMC
September 2019
2 Reads

Identification and functional analysis of missense mutations in the lecithin cholesterol acyltransferase gene in a Chilean patient with hypoalphalipoproteinemia.

Lipids Health Dis 2019 Jun 5;18(1):132. Epub 2019 Jun 5.

Department of Nutrition, Diabetes and Metabolism, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.

Background: Lecithin-cholesterol acyltransferase (LCAT) is a plasma enzyme that esterifies cholesterol in high- and low-density lipoproteins (HDL and LDL). Mutations in LCAT gene causes familial LCAT deficiency, which is characterized by very low plasma HDL-cholesterol levels (Hypoalphalipoproteinemia), corneal opacity and anemia, among other lipid-related traits. Our aim is to evaluate clinical/biochemical features of a Chilean family with a proband showing clinical signs of familial LCAT deficiency, as well as to identify and assess the functional effects of LCAT mutations. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12944-019-1045-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549291PMC
June 2019
6 Reads
2.219 Impact Factor

The P274S Mutation of Lecithin-Cholesterol Acyltransferase (LCAT) and Its Clinical Manifestations in a Large Kindred.

Am J Kidney Dis 2019 10 15;74(4):510-522. Epub 2019 May 15.

Nephrology Department, Heraklion University Hospital, Crete, Greece. Electronic address:

Rationale & Objective: Lecithin-cholesterol acyltransferase (LCAT) catalyzes the maturation of high-density lipoprotein. Homozygosity for loss-of-function mutations causes familial LCAT deficiency (FLD), characterized by corneal opacities, anemia, and renal involvement. This study sought to characterize kidney biopsy findings and clinical outcomes in a family with FLD. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.ajkd.2019.03.422DOI Listing
October 2019
8 Reads

Plasma lipoprotein-X quantification on filipin-stained gels: monitoring recombinant LCAT treatment ex vivo.

J Lipid Res 2019 05 26;60(5):1050-1057. Epub 2019 Feb 26.

Translational Vascular Medicine Branch National Institutes of Health, Bethesda, MD.

Familial LCAT deficiency (FLD) patients accumulate lipoprotein-X (LP-X), an abnormal nephrotoxic lipoprotein enriched in free cholesterol (FC). The low neutral lipid content of LP-X limits the ability to detect it after separation by lipoprotein electrophoresis and staining with Sudan Black or other neutral lipid stains. A sensitive and accurate method for quantitating LP-X would be useful to examine the relationship between plasma LP-X and renal disease progression in FLD patients and could also serve as a biomarker for monitoring recombinant human LCAT (rhLCAT) therapy. Read More

View Article

Download full-text PDF

Source
http://www.jlr.org/lookup/doi/10.1194/jlr.D090233
Publisher Site
http://dx.doi.org/10.1194/jlr.D090233DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6495165PMC
May 2019
32 Reads

Impact of apolipoprotein A1- or lecithin:cholesterol acyltransferase-deficiency on white adipose tissue metabolic activity and glucose homeostasis in mice.

Biochim Biophys Acta Mol Basis Dis 2019 06 10;1865(6):1351-1360. Epub 2019 Feb 10.

University of Patras, School of Medicine, Department of Pharmacology, Rio, Achaias, TK. 26500, Greece. Electronic address:

High density lipoprotein (HDL) has attracted the attention of biomedical community due to its well-documented role in atheroprotection. HDL has also been recently implicated in the regulation of islets of Langerhans secretory function and in the etiology of peripheral insulin sensitivity. Indeed, data from numerous studies strongly indicate that the functions of pancreatic β-cells, skeletal muscles and adipose tissue could benefit from improved HDL functionality. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbadis.2019.02.003DOI Listing
June 2019
10 Reads

Controversy over the atherogenicity of lipoprotein-X.

Curr Opin Endocrinol Diabetes Obes 2019 04;26(2):117-123

Department of Clinical Laboratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.

Purpose Of Review: Lipoprotein-X (Lp-X) is an abnormal lipoprotein containing abundant free cholesterol and phospholipids, as well as some apolipoprotein E (apoE). Serum Lp-X increases in patients with cholestasis and lecithin-cholesterol acyltransferase deficiency, as well as in those receiving intravenous lipid emulsion. Lp-X is often associated with skin xanthomas in cholestatic patients. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MED.0000000000000466DOI Listing
April 2019
15 Reads

Case Report: Management of Corneal Clouding from Lecithin: Cholesterol Acyltransferase Deficiency.

Optom Vis Sci 2019 02;96(2):137-141

Edward S. Harkness Eye Institute, Columbia University Medical Center, New York, New York

Significance: Given that there are few reported cases of lecithin:cholesterol acyltransferase (LCAT) deficiency, recognition of the condition with proper management is notable. Long-term follow-up and contact lens fitting after penetrating keratoplasty provide best possible outcomes.

Purpose: The purpose of this study was to report a case of LCAT deficiency successfully treated with penetrating keratoplasty and longer-term follow-up with contact lens fitting. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/OPX.0000000000001329DOI Listing
February 2019
36 Reads

LCAT Enzyme Replacement Therapy Reduces LpX and Improves Kidney Function in a Mouse Model of Familial LCAT Deficiency.

J Pharmacol Exp Ther 2019 03 18;368(3):423-434. Epub 2018 Dec 18.

Lipoprotein Metabolism Laboratory, Translational Vascular Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland (B.L.V., E.B.N., L.A.F., S.M.G., M.L.S., M.P., E.H., A.T.R.) and MedImmune, Gaithersburg, Maryland (M.J.A., S.K.K.).

Familial LCAT deficiency (FLD) is due to mutations in lecithin:cholesterol acyltransferase (LCAT), a plasma enzyme that esterifies cholesterol on lipoproteins. FLD is associated with markedly reduced levels of plasma high-density lipoprotein and cholesteryl ester and the formation of a nephrotoxic lipoprotein called LpX. We used a mouse model in which the LCAT gene is deleted and a truncated version of the SREBP1a gene is expressed in the liver under the control of a protein-rich/carbohydrate-low (PRCL) diet-regulated PEPCK promoter. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1124/jpet.118.251876DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6374542PMC
March 2019
31 Reads

[Glomerulopathy associated with lecithin-cholesterol-acyltransferase deficiency: A case report and literature review].

Ann Pathol 2019 Apr 12;39(2):172-176. Epub 2018 Dec 12.

Service d'anatomie et cytologie pathologiques, hôpital Timone, 264, rue Saint-Pierre, 13005 Marseille, France; Inserm U1263, C2VN, Aix Marseille université, 13006 Marseille, France.

Glomerulopathy associated with lecithin-cholesterol-acyltransferase deficiency (LCAT) is a rare automosal recessive disease. Acquired LCAT deficiency due to inhibitory autoantibodies against LCAT are also described. This disease is induced by systemic deposits related to a lipid metabolism disorder and lead to multi-organ involvement including renal involvement. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.annpat.2018.09.005DOI Listing
April 2019
6 Reads

A proteomic approach to identify novel disease biomarkers in LCAT deficiency.

J Proteomics 2019 04 6;198:113-118. Epub 2018 Dec 6.

Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Italy. Electronic address:

Genetic LCAT deficiency is a rare recessive autosomal disease due to loss-of-function mutations in the gene coding for the enzyme lecithin:cholesterol acyltransferase (LCAT). Homozygous carriers are characterized by corneal opacity, haemolytic anaemia and renal disease, which represent the first cause of morbidity and mortality in these subjects. Diagnostic and prognostic markers capable of early detecting declining kidney function in these subjects are not available, and the specific serum or urine proteomic signature of LCAT deficient carriers has never been assessed. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jprot.2018.12.005DOI Listing
April 2019
9 Reads

Finding a very rare mutation in non-Caucasian LCAT patients from Southwest Asia for the first time.

J Cell Biochem 2018 Dec 2. Epub 2018 Dec 2.

Genetic laboratory of Amirkola Children's Hospital, Babol University of Medical Sciences, Babol, Iran.

Introduction: Lecithin cholesterol acyltransferase (LCAT) deficiency is an autosomal recessive disorder occurred by different mutations in the LCAT gene that cause two extremely rare syndromes including familial LCAT deficiency (FLD) and fish-eye disease (FED). Unlike FED in FLD renal failure is the most important defect due to deposition of abnormal lipoproteins in the renal stroma. In this study, FLD patients from the North of Iran were investigated for mutations in the LCAT gene. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcb.27981DOI Listing
December 2018
8 Reads

Lipoprotein-X fifty years after its original discovery.

Authors:
R Fellin E Manzato

Nutr Metab Cardiovasc Dis 2019 01 26;29(1):4-8. Epub 2018 Sep 26.

Department of Medicine, University of Padua, Italy. Electronic address:

Aims: To review the formation, catabolism, and the possible atherogenic properties of Lp-X.

Data Synthesis: The conversion of cholesterol to bile acids is regulated by several mechanisms including cholesterol 7 alpha hydroxylase, fibroblast growth factor 19, and farnesoid X receptors. During cholestasis these mechanisms are altered and there is an accumulation of bile acids and cholesterol in plasma. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.numecd.2018.09.006DOI Listing
January 2019
9 Reads

Molecular basis for activation of lecithin:cholesterol acyltransferase by a compound that increases HDL cholesterol.

Elife 2018 11 27;7. Epub 2018 Nov 27.

Department of Biological Sciences, Purdue University, Indiana, United States.

Lecithin:cholesterol acyltransferase (LCAT) and LCAT-activating compounds are being investigated as treatments for coronary heart disease (CHD) and familial LCAT deficiency (FLD). Herein we report the crystal structure of human LCAT in complex with a potent piperidinylpyrazolopyridine activator and an acyl intermediate-like inhibitor, revealing LCAT in an active conformation. Unlike other LCAT activators, the piperidinylpyrazolopyridine activator binds exclusively to the membrane-binding domain (MBD). Read More

View Article

Download full-text PDF

Source
https://elifesciences.org/articles/41604
Publisher Site
http://dx.doi.org/10.7554/eLife.41604DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6277198PMC
November 2018
32 Reads
8.520 Impact Factor

Ocular and Genetic Characteristics Observed in Two Cases of Fish-Eye Disease.

Cornea 2019 Mar;38(3):379-383

Department of Ophthalmology, Haseki Training and Research Hospital, Health Sciences University, Istanbul, Turkey.

Purpose: To present ocular findings and anterior segment-optical coherence tomography (AS-OCT) imaging findings of 2 cases of fish-eye disease (FED) involving 2 novel genetic variants of the lecithin-cholesterol acyltransferase (LCAT) gene.

Methods: A case report.

Results: A 46-year-old woman and 63-year-old man presented with blurred vision, burning sensation, and whitening of both eyes for 2 and 3 years, respectively. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/ICO.0000000000001804DOI Listing
March 2019
15 Reads

Is Low-Density Lipoprotein Cholesterol the Key to Interpret the Role of Lecithin:Cholesterol Acyltransferase in Atherosclerosis?

Circulation 2018 09;138(10):1008-1011

Division of Translational Medicine and Human Genetics, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia (C.V., M.C.).

View Article

Download full-text PDF

Source
https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.118.0
Publisher Site
http://dx.doi.org/10.1161/CIRCULATIONAHA.118.035358DOI Listing
September 2018
50 Reads

Genetic and secondary causes of severe HDL deficiency and cardiovascular disease.

J Lipid Res 2018 12 17;59(12):2421-2435. Epub 2018 Oct 17.

Boston Heart Diagnostics, Framingham, MA 01702

We assessed secondary and genetic causes of severe HDL deficiency in 258,252 subjects, of whom 370 men (0.33%) and 144 women (0.099%) had HDL cholesterol levels <20 mg/dl. Read More

View Article

Download full-text PDF

Source
http://www.jlr.org/lookup/doi/10.1194/jlr.M088203
Publisher Site
http://dx.doi.org/10.1194/jlr.M088203DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6277167PMC
December 2018
51 Reads

Increased oxidative stress and renal injury in patients with sepsis.

J Clin Biochem Nutr 2018 Sep 17;63(2):137-143. Epub 2018 Mar 17.

Division of Emergency and Critical Care Medicine, Department of Acute Medicine, Nihon University School of Medicine, 30-1 Oyaguchi Kamimachi, Itabashi-ku, Tokyo 173-8610, Japan.

Sepsis remains one of the leading causes of death in intensive care units. The early phase of sepsis is characterized by a massive formation of reactive oxygen and nitrogen species such as superoxide and nitric oxide. However, few comprehensive studies on plasma antioxidants have been reported. Read More

View Article

Download full-text PDF

Source
https://www.jstage.jst.go.jp/article/jcbn/63/2/63_17-130/_ar
Publisher Site
http://dx.doi.org/10.3164/jcbn.17-130DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160724PMC
September 2018
45 Reads

Paradoxical fall in proteinuria during pregnancy in an LCAT-deficient patient-A case report.

J Clin Lipidol 2018 Sep - Oct;12(5):1151-1156. Epub 2018 Jul 21.

Renal Unit, Antrim Hospital, Northern Health and Social Care Trust, Antrim, Northern Ireland, UK.

A 29-year-old lady was diagnosed with lecithin:cholesterol acyltransferase (LCAT) deficiency having presented with bilateral corneal clouding, severely reduced high density lipoproteins cholesterol, and proteinuria. She is a compound heterozygote with two LCAT gene mutations, one of which is novel, c.321C>A in exon 3. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S19332874183026
Publisher Site
http://dx.doi.org/10.1016/j.jacl.2018.06.006DOI Listing
October 2019
18 Reads

Lp8 is potentially associated with partial lecithin:cholesterol acyltransferase deficiency in a patient with primary biliary cirrhosis.

J Clin Lipidol 2018 Sep - Oct;12(5):1157-1163. Epub 2018 Jun 22.

Department of Clinical-Laboratory and Experimental-Research Medicine, Toho University Sakura Medical Center, Sakura, Japan. Electronic address:

Background: The significance of Lp8, that is, abnormal lipoprotein(s) detected in fraction 8 by combined high-performance liquid chromatography/gel filtration column in patients with familial lecithin:cholesterol acyltransferase (LCAT) syndrome, in relation to the severity of LCAT deficiency has not been analyzed.

Objective: We have studied Lp8 in a patient with primary biliary cirrhosis.

Methods: Plasma lipoproteins were analyzed using high-performance liquid chromatography/gel filtration column in the course of treatment of a 47-year-old female patient with primary biliary cirrhosis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacl.2018.06.007DOI Listing
October 2019
11 Reads

Immune-mediated acquired lecithin-cholesterol acyltransferase deficiency: A case report and literature review.

J Clin Lipidol 2018 Jul - Aug;12(4):888-897.e2. Epub 2018 May 15.

Department of Clinical Cell Biology and Medicine, Chiba University Graduate School of Medicine, Chiba, Japan.

Background: Recessive inherited disorder lecithin-cholesterol acyltransferase (LCAT) deficiency causes severe hypocholesterolemia and nephrotic syndrome. Characteristic lipoprotein subfractions have been observed in familial LCAT deficiency (FLD) with renal damage.

Objective: We described a case of acquired LCAT deficiencies with literature review. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S19332874183021
Publisher Site
http://dx.doi.org/10.1016/j.jacl.2018.05.002DOI Listing
October 2019
60 Reads

Niemann-Pick C1-deficient mice lacking sterol O-acyltransferase 2 have less hepatic cholesterol entrapment and improved liver function.

Am J Physiol Gastrointest Liver Physiol 2018 10 7;315(4):G454-G463. Epub 2018 Jun 7.

Department of Internal Medicine, University of Texas Southwestern Medical Center , Dallas, Texas.

Cholesteryl esters are generated at multiple sites in the body by sterol O-acyltransferase (SOAT) 1 or SOAT2 in various cell types and lecithin cholesterol acyltransferase in plasma. Esterified cholesterol and triacylglycerol contained in lipoproteins cleared from the circulation via receptor-mediated or bulk-phase endocytosis are hydrolyzed by lysosomal acid lipase within the late endosomal/lysosomal (E/L) compartment. Then, through the successive actions of Niemann-Pick C (NPC) 2 and NPC 1, unesterified cholesterol (UC) is exported from the E/L compartment to the cytosol. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1152/ajpgi.00124.2018DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6230690PMC
October 2018
48 Reads

Plasma PCSK9 levels and lipoprotein distribution are preserved in carriers of genetic HDL disorders.

Biochim Biophys Acta Mol Cell Biol Lipids 2018 09 29;1863(9):991-997. Epub 2018 May 29.

Centro E. Grossi Paoletti, Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Italy. Electronic address:

Proprotein convertase subtilisin/kexin 9 (PCSK9), a protein regulating the number of cell-surface LDL receptors (LDLR), circulates partially associated to plasma lipoproteins. How this interaction alters PCSK9 plasma levels is still unclear. In the present study, we took advantage of the availability of a large cohort of carriers of genetic HDL disorders to evaluate how HDL defects affect plasma PCSK9 levels and its distribution among lipoproteins. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbalip.2018.05.015DOI Listing
September 2018
19 Reads

Complete and Partial Lecithin:Cholesterol Acyltransferase Deficiency Is Differentially Associated With Atherosclerosis.

Circulation 2018 09;138(10):1000-1007

Centro E. Grossi Paoletti, Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Italy (A.O., S.S., G.F., L.C.).

Background: Lecithin:cholesterol acyltransferase (LCAT) is the sole enzyme that esterifies cholesterol in plasma. Its role in the supposed protection from atherogenesis remains unclear because mutations in LCAT causing fish-eye disease (FED) or familial LCAT deficiency (FLD) have been reported to be associated with more or instead less carotid atherosclerosis, respectively. This discrepancy may be associated with the loss of cholesterol esterification on only apolipoprotein AI (FED) or on both apolipoprotein AI- and apolipoprotein B-containing lipoproteins (FLD), an aspect that has thus far not been investigated. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.118.034706DOI Listing
September 2018
50 Reads

Anionic nanoliposomes reduced atherosclerosis progression in Low Density Lipoprotein Receptor (LDLR) deficient mice fed a high fat diet.

J Cell Physiol 2018 10 9;233(10):6951-6964. Epub 2018 May 9.

Queensland Research Centre for Peripheral Vascular Disease, College of Medicine and Dentistry, James Cook University, Townsville, Queensland, Australia.

Atherosclerosis is a systemic disease characterized by the deposition of cholesterol and inflammatory cells within the arterial wall. Removal of cholesterol from the vessel wall may have an impact on the size and composition of atherosclerotic lesions. Anionic phospholipids or liposome vesicles composed of a lipid bilayer such as nanoliposomes have been suggested as treatments for dyslipidemia. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcp.26610DOI Listing
October 2018
54 Reads

Clinical features and visual function in a patient with Fish-eye disease: Quantitative measurements and optical coherence tomography.

Am J Ophthalmol Case Rep 2018 Jun 24;10:137-141. Epub 2018 Feb 24.

Department of Ophthalmology, Osaka University Graduate School of Medicine, Osaka, Japan.

Purpose: We describe a case of fish-eye disease (FED) where the clinical features and visual function were investigated using anterior segment optical coherence tomography (OCT) and quantitative measurements.

Observations: A 36-year-old Japanese woman with FED presented with bilateral corneal opacities and visual complaints. Both contrast sensitivity and straylight were measured and OCT imaging was performed. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajoc.2018.02.016DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5910509PMC
June 2018
11 Reads

Undetectable high-density lipoprotein cholesterol in acute malaria.

J Clin Lipidol 2018 May - Jun;12(3):822-825. Epub 2018 Mar 9.

Guy's, St Thomas' and Lewisham and Greenwich Trust, St. Thomas' Hospital, London, United Kingdom.

We report the case of a 39-year-old West African man in whom high-density lipoprotein cholesterol (HDL-C) was identified as undetectable at <0.08 mmol/L. Total cholesterol in the same sample was 2. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacl.2018.02.019DOI Listing
September 2019
24 Reads

LCAT deficiency as a cause of proteinuria and corneal opacification.

BMJ Case Rep 2018 Mar 13;2018. Epub 2018 Mar 13.

Department of Internal Medicine, Hospital Universitario 12 de Octubre, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bcr-2017-224129DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5878272PMC
March 2018
11 Reads

Loss of LCAT activity in the golden Syrian hamster elicits pro-atherogenic dyslipidemia and enhanced atherosclerosis.

Metabolism 2018 06 9;83:245-255. Epub 2018 Mar 9.

Institute of Cardiovascular Sciences, Key Laboratory of Molecular Cardiovascular Sciences, Ministry of Education, Peking University, Beijing 100191, China. Electronic address:

Objective: Lecithin cholesterol acyltransferase (LCAT) plays a pivotal role in HDL metabolism but its influence on atherosclerosis remains controversial for decades both in animal and clinical studies. Because lack of cholesteryl ester transfer protein (CETP) is a major difference between murine and humans in lipoprotein metabolism, we aimed to create a novel Syrian Golden hamster model deficient in LCAT activity, which expresses endogenous CETP, to explore its metabolic features and particularly the influence of LCAT on the development of atherosclerosis.

Methods: CRISPR/CAS9 gene editing system was employed to generate mutant LCAT hamsters. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.metabol.2018.03.003DOI Listing
June 2018
26 Reads

A Novel Approach to the Treatment of Plasma Protein Deficiency: Ex Vivo-Manipulated Adipocytes for Sustained Secretion of Therapeutic Proteins.

Chem Pharm Bull (Tokyo) 2018 ;66(3):217-224

Clinical Cell Biology and Medicine, Chiba University Graduate School of Medicine, Chiba University.

Despite the critical need for lifelong treatment of inherited and genetic diseases, there are no developmental efforts for most such diseases due to their rarity. Recent progress in gene therapy, including the approvals of two products (Glybera and Strimvelis) that may provide patients with sustained effects, has shed light on the development of gene therapy products. Most gene therapy products are based on either adeno-associated virus-mediated in vivo gene transfer to target tissues or administration of ex vivo gene-transduced hematopoietic cells. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1248/cpb.c17-00786DOI Listing
March 2018
23 Reads

Novel metabolic phenotypes in lecithin cholesterol acyltyransferase-deficient mice.

Authors:
Dominic S Ng

Curr Opin Lipidol 2018 04;29(2):104-109

Purpose Of Review: Lecithin cholesterol acyltyransferase (LCAT) deficiency is a rare monogenic disorder causing lipoprotein dysregulation and multiple organ dysfunctions, including renal impairment. LCAT knockout mice have been shown informative in elucidating mechanisms of many major clinical morbid phenotypes. Extended characterization of the LDL receptor/LCAT double knockout (Ldlr/Lcat-DKO or DKO) mice had led to the discovery of a number of novel protective metabolic phenotypes, including resistance to obesity, nonalcoholic steatohepatitis (NASH) and insulin resistance. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOL.0000000000000486DOI Listing
April 2018
5 Reads

Novel Missense LCAT Gene Mutation Associated with an Atypical Phenotype of Familial LCAT Deficiency in Two Portuguese Brothers.

JIMD Rep 2018 6;40:55-62. Epub 2017 Oct 6.

I3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Rua Alfredo Allen 208, 4200-135, Oporto, Portugal.

Familial lecithin-cholesterol acyltransferase deficiency (FLD) is a rare recessive disorder of cholesterol metabolism, caused by loss-of-function mutations in the human LCAT gene, leading to alterations in the lipid/lipoprotein profile, with extremely low HDL levels.The classical FLD phenotype is characterized by diffuse corneal opacification, haemolytic anaemia and proteinuric chronic kidney disease (CKD); an incomplete form, only affecting the corneas, has been reported in a few families worldwide.We describe an intermediate phenotype of LCAT deficiency, with CKD preceding the development of corneal clouding, in two Portuguese brothers apparently homozygous for a novel missense LCAT gene mutation. Read More

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/8904_2017_57
Publisher Site
http://dx.doi.org/10.1007/8904_2017_57DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122021PMC
October 2017
55 Reads

Oxidative stress and abnormal cholesterol metabolism in patients with post-cardiac arrest syndrome.

J Clin Biochem Nutr 2017 Sep 28;61(2):108-117. Epub 2017 Jul 28.

School of Bioscience and Biotechnology, Tokyo University of Technology, 1404-1 Katakura-cho, Hachioji, Tokyo 192-0982, Japan.

Patients with post-cardiac arrest syndrome (PCAS) suffer from whole body ischemia/reperfusion injury similar to that experienced by newborn babies. Increased oxidative stress was confirmed in PCAS patients ( = 40) at the time of hospitalization by a significant increase in the percentage of the oxidized form of coenzyme Q10 in total coenzyme Q10 compared to age-matched healthy controls ( = 55). Tissue oxidative damage in patients was suggested by the significant increase in plasma levels of free fatty acids (FFA) and the significant decrease in polyunsaturated fatty acid contents in total FFA. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3164/jcbn.17-30DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5612819PMC
September 2017
15 Reads

A novel homozygous mutation causing lecithin-cholesterol acyltransferase deficiency in a proband of Romanian origin with a record of extreme gestational hyperlipidemia.

J Clin Lipidol 2017 Nov - Dec;11(6):1475-1479.e3. Epub 2017 Aug 24.

Departamento de Medicina Interna, Servicio de Medicina Interna, Hospital Universitario de Guadalajara, Servicio de Salud de Castilla La Mancha, Guadalajara, Castilla la Mancha, Spain; Departamento de Medicina, Universidad de Alcalá, Madrid, Spain.

A patient from Romania with extraordinarily high total cholesterol levels and clinical and biochemical features consistent with familial lecithin-cholesterol acyltransferase deficiency is reported. The genetic analysis performed on our proband showed a novel homozygous mutation on codon 119 of lecithin-cholesterol acyltransferase gene that causes the substitution of glycine by aspartate. The same mutation, also in homozygosis, was observed in her older sister, whereas his brother presented it in heterozygosis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacl.2017.08.008DOI Listing
July 2018
13 Reads

Development of a novel fluorescent activity assay for lecithin:cholesterol acyltransferase.

Ann Clin Biochem 2018 Jul 2;55(4):414-421. Epub 2017 Nov 2.

1 Lipoprotein Metabolism Section, Cardio-Pulmonary Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.

Background Lecithin:cholesterol acyltransferase (LCAT) is a plasma enzyme that esterifies cholesterol. Recombinant human LCAT (rhLCAT) is now being developed as an enzyme replacement therapy for familial LCAT deficiency and as a possible treatment for acute coronary syndrome. The current 'gold standard' assay for LCAT activity involves the use of radioisotopes, thus making it difficult for routine clinical use. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0004563217733285DOI Listing
July 2018
70 Reads

AJKD Atlas of Renal Pathology: Lecithin-Cholesterol Acyltransferase (LCAT) Deficiency.

Am J Kidney Dis 2017 Jul;70(1):e5-e6

Department of Pathology, Microbiology and Immunology, Vanderbilt University, Nashville, TN. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.ajkd.2017.05.003DOI Listing
July 2017
12 Reads

Lecithin:Cholesterol Acyltransferase Activation by Sulfhydryl-Reactive Small Molecules: Role of Cysteine-31.

J Pharmacol Exp Ther 2017 08 2;362(2):306-318. Epub 2017 Jun 2.

Lipid Metabolism Section, Cardiovascular and Pulmonary Branch (L.A.F., S.J.D., S.M.G., B.L.V., R.D.S., A.T.R.), Systems Biology Center (A.A., M.G.), and Laboratory of Biochemistry (R.L.L.), National Institutes of Health National Heart, Lung, and Blood Institute, Bethesda, Maryland; Department of Chemistry, American University, Washington, DC (M.K., R.K.); University of Milano, Milano, Italy (A.F.O., L.C.); Department of Chemistry, Vanderbilt University, Nashville, Tennessee (R.F.K.); Departments of Pharmacology and Biological Chemistry, Life Sciences Institute, University of Michigan, Ann Arbor, Michigan (K.A.M., J.J.G.T.); and National Institutes of Health National Center for Advancing Translational Sciences, Bethesda, Maryland (M.S., A.J.)

Lecithin:cholesterol acyltransferase (LCAT) catalyzes plasma cholesteryl ester formation and is defective in familial lecithin:cholesterol acyltransferase deficiency (FLD), an autosomal recessive disorder characterized by low high-density lipoprotein, anemia, and renal disease. This study aimed to investigate the mechanism by which compound A [3-(5-(ethylthio)-1,3,4-thiadiazol-2-ylthio)pyrazine-2-carbonitrile], a small heterocyclic amine, activates LCAT. The effect of compound A on LCAT was tested in human plasma and with recombinant LCAT. Read More

View Article

Download full-text PDF

Source
http://jpet.aspetjournals.org/lookup/doi/10.1124/jpet.117.24
Publisher Site
http://dx.doi.org/10.1124/jpet.117.240457DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5510151PMC
August 2017
57 Reads

A case of acquired lecithin:cholesterol acyltransferase deficiency with sarcoidosis that remitted spontaneously.

CEN Case Rep 2016 Nov 7;5(2):192-196. Epub 2016 Jun 7.

Department of Clinical-Laboratory and Experimental-Research Medicine, Toho University Sakura Medical Center, Sakura, Chiba, 285-8741, Japan.

Familial lecithin:cholesterol acyltransferase (LCAT) deficiency is a rare inherited disorder that causes an extremely low high-density lipoprotein cholesterol concentration in serum. Recently, acquired LCAT deficiency caused by IgG antibodies to LCAT, without any LCAT gene mutation, was reported. Here we describe a case of acquired LCAT deficiency occurring in association with sarcoidosis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13730-016-0223-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5411646PMC
November 2016
42 Reads

Featured Article: Depletion of HDL high density lipoprotein and altered functionality of HDL in blood from sickle cell patients.

Exp Biol Med (Maywood) 2017 06 24;242(12):1244-1253. Epub 2017 Apr 24.

Children's Hospital Oakland Research Institute, Oakland, CA 94609, USA.

In sickle cell disease (SCD), alterations of cholesterol metabolism is in part related to abnormal levels and activity of plasma proteins such as lecithin cholesterol acyltransferase (LCAT), and apolipoprotein A-I (ApoA-I). In addition, the size distribution of ApoA-I high density lipoproteins (HDL) differs from normal blood. The ratio of the amount of HDL particle relative to the smaller higher density pre-β HDL (HDL) particle was shifted toward HDL. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1535370217706966DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5476340PMC
June 2017
11 Reads

The function of lecithin:cholesterol acyltransferase (LCAT).

Authors:
Kaare R Norum

Scand J Clin Lab Invest 2017 07 10;77(4):235-236. Epub 2017 Apr 10.

a Department of Nutrition , University of Oslo , Oslo , Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/00365513.2017.1308008DOI Listing
July 2017
33 Reads

Depletion in LpA-I:A-II particles enhances HDL-mediated endothelial protection in familial LCAT deficiency.

J Lipid Res 2017 05 28;58(5):994-1001. Epub 2017 Mar 28.

Centro E. Grossi Paoletti, Dipartimento di Scienze Farmacologiche e Biomolecolari Università degli Studi di Milano, Milano, Italy

The aim of this study was to evaluate the vasoprotective effects of HDL isolated from carriers of LCAT deficiency, which are characterized by a selective depletion of LpA-I:A-II particles and predominance of preβ migrating HDL. HDLs were isolated from LCAT-deficient carriers and tested in vitro for their capacity to promote NO production and to inhibit vascular cell adhesion molecule-1 (VCAM-1) expression in cultured endothelial cells. HDLs from carriers were more effective than control HDLs in promoting eNOS activation with a gene-dose-dependent effect ( = 0. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1194/jlr.P072371DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5408617PMC
May 2017
50 Reads

Deficient Cholesterol Esterification in Plasma of apoc2 Knockout Zebrafish and Familial Chylomicronemia Patients.

PLoS One 2017 20;12(1):e0169939. Epub 2017 Jan 20.

Department of Medicine, University of California San Diego, La Jolla, California, United States of America.

Hypertriglyceridemia is an independent risk factor for cardiovascular disease. Apolipoprotein C-II (APOC2) is an obligatory cofactor for lipoprotein lipase (LPL), the major enzyme catalyzing plasma triglyceride hydrolysis. We have created an apoc2 knockout zebrafish model, which mimics the familial chylomicronemia syndrome (FCS) in human patients with a defect in the APOC2 or LPL gene. Read More

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0169939PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5249157PMC
August 2017
32 Reads

The Case | Nephrotic syndrome with corneal opacities.

Kidney Int 2017 02;91(2):515-516

Department of Nephrology, Istanbul Medeniyet University, Goztepe Training and Research Hospital, Istanbul, Turkey.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.kint.2016.07.005DOI Listing
February 2017
29 Reads
8.563 Impact Factor

[Glomerular lipidosis].

Authors:
Sandro Feriozzi

G Ital Nefrol 2016 Malattie Metaboliche e Rene;33(S68)

Lipidoses occur for an abnormal storage parenchymal deposition of lipids and products of their metabolism in large amounts or sometimes, involving only some particular tissue structures. The lipid storage is usually due to an inborn error causing an enzyme absence /deficiency in the primary lipidoses and to a complex metabolism alterations in the secondary forms. However, histologically all lipid depositions look very similar, and immunohistochemical investigation, clinical pictures knowledge and genetic tests need to make a correct diagnosis. Read More

View Article

Download full-text PDF

Source
October 2017
8 Reads

[Lecithin:Cholesterol Acyltransferase Deficiency, from genes to therapy].

G Ital Nefrol 2016 Malattie Metaboliche e Rene;33(S68)

LCAT synthesizes most of the plasma cholesteryl esters, and plays a major role in HDL metabolism. Mutations in the LCAT gene cause two syndromes, familial LCAT deficiency (FLD) and fish-eye disease (FED), both characterized by severe alterations in plasma lipoprotein profile. Renal disease is the major cause of morbidity and mortality in FLD cases, but an established therapy is not currently available. Read More

View Article

Download full-text PDF

Source
October 2017
24 Reads